| 中文名称: | 2-(4-(2-氟-5-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)苯基)-1H-吡唑-1-基)乙醇 |
| 中文别名: | R-268712;ALK5抑制剂(R-268712);化合物R-268712;2-(4-(2-氟-5-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)苯基)-1H-吡唑-1-基)乙醇;4-[2-氟-5-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]苯基]-1H-吡唑-1-乙醇 |
| smiles: | FC1C(C2=CN(CCO)N=C2)=CC(C2C(C3C=CC=C(C)N=3)=NNC=2)=CC=1 |
| 英文名称: | R268712 |
| 英文别名: | R 268712;R-268712;R268712;2-[4-[2-Fluoro-5-[3-(6-methylpyridine-2-yl)-1H-pyrazol-4-yl] phenyl] pyrazol-1-yl]ethanol;2-[4-[2-fluoro-5-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]phenyl]pyrazol-1-yl]ethanol;AMY16880;BCP25191;4-[2-Fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-1H-pyrazole-1-ethanol;CID 11703284;2025;1H-Pyrazole-1-ethanol, 4-[2-fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-;2-(4-(2-Fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol;renal fibrosis,Thy1 nephritis,Transforming growth factor beta receptors,glomerulonephritis,Transforming growth factor beta,ALK tyrosine kinase receptor,HFL-1,R 268712,glomerulosclerosis,CD246,Inhibitor,Cluster of differentiation 246,UUO,Anaplastic lymphoma kinase (ALK),R268712,inhibit,TGF-β,TGF-beta/Smad,CKD,R-268712,TGF-β Receptor,Anaplastic lymphoma kinase;4-[2-Fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-1H-pyrazole-1-ethanol (ACI);2-[4-[2-Fluoro-5-[3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]phenyl]-1H-pyrazol-1-yl]ethanol;2-[4-[2-Fluoro-5-[3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]phenyl]pyrazol-1-yl]ethanol;2-[4-[2-Fluoro-5-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]phenyl]pyrazol-1-yl]ethanol |
| CAS号: | 879487-87-3 |
| 分子式: | C20H18FN5O |
| 分子量: | 363.39 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
2-(4-(2-氟-5-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)苯基)-1H-吡唑-1-基)乙醇
英文名:
R268712
别名:R-268712;ALK5抑制剂(R-268712);化合物R-268712;2-(4-(2-氟-5-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)苯基)-1H-吡唑-1-基)乙醇;4-[2-氟-5-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]苯基]-1H-吡唑-1-乙醇
商品编号:R067345-1mg
规格:1mg
纯度:≥99%
CAS号: 879487-87-3
分子式:C20H18FN5O
分子量:363.39
| 价格 |
¥ 120.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















